Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jul 21, 2016; 22(27): 6246-6256
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6246
Figure 1
Figure 1 Panel of immunohistochemical markers. Ki67 in A: Cirrhosis (low); B: Grade 2 (low); C: Grade 3 (moderate); D: Grade 4 (high). K19 in E: Cirrhosis (negative in hepatocytes); F: Grade 3 (focal); G: Grade 3 (moderate); H: Grade 4 (moderate); p53 in I: Cirrhosis (negative); J: Grade 2 (focal); K: Grade 3 (moderate); L: Grade 3 (diffuse). ERK1 in M: Cirrhosis (negative); N: Grade 2 (weak); O: Grade 3 (moderate); P: Grade 3 (strong). Beta-catenin in Q: Cirrhosis (strong membrane expression); R: Grade 2 (weak membrane); S: Grade 3 (strong membrane); T: Grade 4 (nuclear expression). ERK2 in U: Cirrhosis (negative in hepatocytes and positive in endothelial cells); V: Grade 2 (negative); W: Grade 3 (moderate); X: Grade 3 (strong). Original magnification × 400.